Adaptive Phage Therapeutics
Gaithersburg, US · Founded 2017 · Delaware corporation · 2 known investors
Founders & leadership
Adaptive Phage Therapeutics was founded in 2017 by Gregory L. Merril and Carl R. Merril.
GL
Gregory L. MerrilCo-founder
CR
Carl R. MerrilCo-founder
Board
JL
EL
Evan LohBoard director
JJ
Jana JensenBoard director
RL
Raymond L. MartzBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$45.8M disclosed across 5 of 6 rounds · 2017–2023
▶$12MraisedJun 2023 · 4 investors · BiotechnologyRule 506(b)
▶$12MraisedJun 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan LeffDirector
- Jana JensenDirector
- Carl R. MerrilDirector
- Ian HardyDirector
- Michael OrndorffExecutive Officer
- Gregory L. MerrilExecutive Officer, Director, Promoter
- Jesse GoodmanDirector
- Raymond L. MartzDirector
- Martin HeideckerDirector
- Evan LohDirector
- Subhendu BasuExecutive Officer
- Offering amount
- $30M
- Amount sold
- $12M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.3MraisedMay 2021 · 59 investors · BiotechnologyRule 506(b)
▶$23.3MraisedMay 2021 · 59 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evan LohDirector
- Gregory L. MerrilExecutive Officer, Director, Promoter
- Jonathan LeffDirector
- Jana JensenDirector
- Raymond L. MartzDirector
- Carl R. MerrilExecutive Officer, Director
- Offering amount
- $53.3M
- Amount sold
- $23.3M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.6MofferedAug 2020 · PharmaceuticalsRule 506(c)
▶$3.6MofferedAug 2020 · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Subhendu BasuExecutive Officer
- Gregory Louis MerrilExecutive Officer, Director
- Carl MerrilExecutive Officer, Director
- Raymond MartzDirector
- Offering amount
- $3.6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$2.8MraisedJun 2020 · 12 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedJun 2020 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gregory Louis MerrilExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $2.8M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$7MraisedNov 2019 · 40 investors · PharmaceuticalsRule 506(b)
▶$7MraisedNov 2019 · 40 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gregory Louis MerrilExecutive Officer, Director
- Raymond MartzDirector
- Carl MerrilExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$765KraisedApr 2017 · 10 investors · PharmaceuticalsRule 506(b)
▶$765KraisedApr 2017 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gregory MerrilExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $765K
- Minimum investment
- $10K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Adaptive Phage Therapeutics?
- Adaptive Phage Therapeutics was founded by Gregory L. Merril, Carl R. Merril in 2017.
- Who are Adaptive Phage Therapeutics's investors?
- Adaptive Phage Therapeutics's investors include AMR Action Fund, Sofinnova Ventures.
- How much funding has Adaptive Phage Therapeutics raised?
- Adaptive Phage Therapeutics has disclosed $45.8M raised across 5 of its 6 known rounds.
- Where is Adaptive Phage Therapeutics headquartered?
- Adaptive Phage Therapeutics is headquartered in Gaithersburg, US.